{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T10:11:03Z","timestamp":1764843063639,"version":"3.46.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-025-04490-9","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T10:05:02Z","timestamp":1764842702000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Successful application of innovative hybrid anticoagulation in continuous renal replacement therapy for an ultra-elderly patient: a case report"],"prefix":"10.1186","volume":"26","author":[{"given":"Yaping","family":"Ye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziqiang","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuyue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianghong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minhua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,24]]},"reference":[{"issue":"1","key":"4490_CR1","doi-asserted-by":"publisher","first-page":"20616","DOI":"10.1038\/s41598-020-76785-w","volume":"10","author":"EF Ruiz","year":"2020","unstructured":"Ruiz EF, Ortiz-Soriano VM, Talbott M, Klein BA, Thompson Bastin ML, Mayer KP, Price EB, Dorfman R, Adams BN, Fryman L, et al. Development, implementation and outcomes of a quality assurance system for the provision of continuous renal replacement therapy in the intensive care unit. Sci Rep. 2020;10(1):20616.","journal-title":"Sci Rep"},{"issue":"1","key":"4490_CR2","first-page":"23","volume":"10","author":"SY Liu","year":"2023","unstructured":"Liu SY, Xu SY, Yin L, Yang T, Jin K, Zhang QB, Sun F, Tan DY, Xin TY, Chen YG, et al. Management of regional citrate anticoagulation for continuous renal replacement therapy: guideline recommendations from Chinese emergency medical Doctor consensus. Mil Med Res. 2023;10(1):23.","journal-title":"Mil Med Res"},{"issue":"6","key":"4490_CR3","doi-asserted-by":"publisher","first-page":"571","DOI":"10.2174\/092986710790416326","volume":"17","author":"A Corsonello","year":"2010","unstructured":"Corsonello A, Pedone C, Incalzi RA. Age-related Pharmacokinetic and pharmacodynamic changes and related risk of adverse drug reactions. Curr Med Chem. 2010;17(6):571\u201384.","journal-title":"Curr Med Chem"},{"issue":"4","key":"4490_CR4","doi-asserted-by":"publisher","first-page":"c179","DOI":"10.1159\/000339789","volume":"120","author":"A Khwaja","year":"2012","unstructured":"Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120(4):c179\u2013184.","journal-title":"Nephron Clin Pract"},{"issue":"1","key":"4490_CR5","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s13054-016-1299-0","volume":"20","author":"C Liu","year":"2016","unstructured":"Liu C, Mao Z, Kang H, Hu J, Zhou F. Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients: a meta-analysis with trial sequential analysis of randomized controlled trials. Crit Care. 2016;20(1):144.","journal-title":"Crit Care"},{"issue":"1","key":"4490_CR6","doi-asserted-by":"publisher","first-page":"6607","DOI":"10.1038\/s41598-019-42916-1","volume":"9","author":"J Gao","year":"2019","unstructured":"Gao J, Wang F, Wang Y, Jin D, Tang L, Pan K. A mode of CVVH with regional citrate anticoagulation compared to no anticoagulation for acute kidney injury patients at high risk of bleeding. Sci Rep. 2019;9(1):6607.","journal-title":"Sci Rep"},{"issue":"16","key":"4490_CR7","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1001\/jama.2020.18618","volume":"324","author":"A Zarbock","year":"2020","unstructured":"Zarbock A, K\u00fcllmar M, Kindgen-Milles D, Wempe C, Gerss J, Brandenburger T, Dimski T, Tyczynski B, Jahn M, M\u00fclling N, et al. Effect of regional citrate anticoagulation vs systemic heparin anticoagulation during continuous kidney replacement therapy on dialysis filter life span and mortality among critically ill patients with acute kidney injury: A randomized clinical trial. JAMA. 2020;324(16):1629\u201339.","journal-title":"JAMA"},{"key":"4490_CR8","doi-asserted-by":"crossref","unstructured":"Mariano F, Mella A, Randone P, Agostini F, Bergamo D, Berardino M, Biancone L, et al Safety and metabolic tolerance of citrate anticoagulation in critically ill polytrauma patients with acute kidney injury requiring an early continuous kidney replacement therapy. Biomedicines. 2023;11(9).","DOI":"10.3390\/biomedicines11092570"},{"issue":"1","key":"4490_CR9","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s40001-024-01660-7","volume":"29","author":"D Liu","year":"2024","unstructured":"Liu D, Zhao J, Xia H, Dong S, Yan S, Zhuang Y, Chen Y, Peng H. Nafamostat mesylate versus regional citrate anticoagulation for continuous renal replacement therapy in patients at high risk of bleeding: a retrospective single-center study. Eur J Med Res. 2024;29(1):72.","journal-title":"Eur J Med Res"},{"issue":"2","key":"4490_CR10","doi-asserted-by":"publisher","first-page":"151","DOI":"10.2215\/CJN.0000000000000351","volume":"19","author":"M Bai","year":"2024","unstructured":"Bai M, Yu Y, Zhao L, Tian X, Zhou M, Jiao J, Liu Y, Li Y, Yue Y, Wei L, et al. Regional citrate anticoagulation versus no anticoagulation for CKRT in patients with liver failure with increased bleeding risk. Clin J Am Soc Nephrol. 2024;19(2):151\u201360.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"4490_CR11","doi-asserted-by":"publisher","first-page":"e941","DOI":"10.1097\/CCM.0000000000002501","volume":"45","author":"D Khadzhynov","year":"2017","unstructured":"Khadzhynov D, Dahlinger A, Schelter C, Peters H, Kindgen-Milles D, Budde K, Lehner LJ, Halleck F, Staeck O, Slowinski T. Hyperlactatemia, lactate kinetics and prediction of citrate accumulation in critically ill patients undergoing continuous renal replacement therapy with regional citrate anticoagulation. Crit Care Med. 2017;45(9):e941\u20136.","journal-title":"Crit Care Med"},{"issue":"4","key":"4490_CR12","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1177\/03913988211003586","volume":"45","author":"L Li","year":"2022","unstructured":"Li L, Bai M, Zhang W, Zhao L, Yu Y, Sun S. Regional citrate anticoagulation versus low molecular weight heparin for CRRT in hyperlactatemia patients: A retrospective case-control study. Int J Artif Organs. 2022;45(4):343\u201350.","journal-title":"Int J Artif Organs"},{"issue":"1","key":"4490_CR13","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13054-019-2317-9","volume":"23","author":"W Zhang","year":"2019","unstructured":"Zhang W, Bai M, Yu Y, Li L, Zhao L, Sun S, Chen X. Safety and efficacy of regional citrate anticoagulation for continuous renal replacement therapy in liver failure patients: a systematic review and meta-analysis. Crit Care. 2019;23(1):22.","journal-title":"Crit Care"},{"issue":"12","key":"4490_CR14","doi-asserted-by":"publisher","first-page":"3882","DOI":"10.1093\/ndt\/gfr106","volume":"26","author":"F Mariano","year":"2011","unstructured":"Mariano F, Morselli M, Bergamo D, Hollo Z, Scella S, Maio M, Tetta C, Dellavalle A, Stella M, Triolo G. Blood and ultrafiltrate dosage of citrate as a useful and routine tool during continuous venovenous haemodiafiltration in septic shock patients. Nephrol Dial Transpl. 2011;26(12):3882\u20138.","journal-title":"Nephrol Dial Transpl"},{"issue":"5","key":"4490_CR15","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1046\/j.1526-0968.2003.00088.x","volume":"7","author":"H Nakae","year":"2003","unstructured":"Nakae H, Tajimi K. Pharmacokinetics of Nafamostat mesilate during continuous hemodiafiltration with a polyacrylonitrile membrane. Ther Apher Dial. 2003;7(5):483\u20135.","journal-title":"Ther Apher Dial"},{"key":"4490_CR16","unstructured":"Park II, Choi MJ, Yoon JW, Lee YK, Kim SG, Oh JE, Seo JW, Kim HJ, Noh JW, Koo JR. Saline versus nafamostat mesilate anticoagulation for continuous veno-venous hemofiltration (CVVH) in patients at high risk of bleeding: a prospective study. Korean J Nephrol. 2009;28(3):205-10."},{"issue":"10","key":"4490_CR17","doi-asserted-by":"publisher","first-page":"e108737","DOI":"10.1371\/journal.pone.0108737","volume":"9","author":"YK Lee","year":"2014","unstructured":"Lee YK, Lee HW, Choi KH, Kim BS. Ability of Nafamostat mesilate to prolong filter patency during continuous renal replacement therapy in patients at high risk of bleeding: a randomized controlled study. PLoS ONE. 2014;9(10):e108737.","journal-title":"PLoS ONE"},{"issue":"1","key":"4490_CR18","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1080\/0886022X.2022.2105233","volume":"44","author":"Y Lin","year":"2022","unstructured":"Lin Y, Shao Y, Liu Y, Yang R, Liao S, Yang S, Xu M, He J. Efficacy and safety of Nafamostat mesilate anticoagulation in blood purification treatment of critically ill patients: a systematic review and meta-analysis. Ren Fail. 2022;44(1):1263\u201379.","journal-title":"Ren Fail"},{"issue":"44","key":"4490_CR19","first-page":"4022","volume":"104","author":"XF Sun","year":"2024","unstructured":"Sun XF. [Proposal of anticoagulant strategies in continuous renal replacement therapy]. Zhonghua Yi Xue Za Zhi. 2024;104(44):4022\u20136.","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"11","key":"4490_CR20","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1007\/s00467-022-05502-8","volume":"37","author":"MJ Miyaji","year":"2022","unstructured":"Miyaji MJ, Ide K, Takashima K, Maeno M, Krallman KA, Lazear D, Goldstein SL. Comparison of Nafamostat mesilate to citrate anticoagulation in pediatric continuous kidney replacement therapy. Pediatr Nephrol. 2022;37(11):2733\u201342.","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"4490_CR21","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12882-023-03060-1","volume":"24","author":"S Kameda","year":"2023","unstructured":"Kameda S, Fujii T, Ikeda J, Kageyama A, Takagi T, Miyayama N, Asano K, Endo A, Uezono S. Unfractionated heparin versus Nafamostat mesylate for anticoagulation during continuous kidney replacement therapy: an observational study. BMC Nephrol. 2023;24(1):12.","journal-title":"BMC Nephrol"},{"issue":"3","key":"4490_CR22","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/s41390-024-03163-x","volume":"96","author":"SK Atis","year":"2024","unstructured":"Atis SK, Duyu M, Karakaya Z, Yilmaz A. Citrate anticoagulation and systemic heparin anticoagulation during continuous renal replacement therapy among critically-ill children. Pediatr Res. 2024;96(3):702\u201312.","journal-title":"Pediatr Res"},{"key":"4490_CR23","doi-asserted-by":"crossref","unstructured":"Rezu\u015f E, Burlui A, Cardoneanu A, Rezu\u015f C, Codreanu C, P\u00e2rvu M, Rusu Zota G, Tamba BI. Inactivity and skeletal muscle metabolism: a vicious cycle in old age. Int J Mol Sci. 2020;21(2).","DOI":"10.3390\/ijms21020592"},{"issue":"9","key":"4490_CR24","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/S2468-1253(20)30006-6","volume":"5","author":"MI Lucena","year":"2020","unstructured":"Lucena MI, Sanabria J, Garc\u00eda-Cortes M, Stephens C, Andrade RJ. Drug-induced liver injury in older people. LGH. 2020;5(9):862\u201374.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"5","key":"4490_CR25","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1182\/blood-2017-07-746446","volume":"131","author":"R Stauder","year":"2018","unstructured":"Stauder R, Valent P, Theurl I. Anemia at older age: etiologies, clinical implications, and management. Blood. 2018;131(5):505\u201314.","journal-title":"Blood"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04490-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04490-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04490-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T10:05:13Z","timestamp":1764842713000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-025-04490-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4490"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04490-9","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,24]]},"assertion":[{"value":"18 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Research Ethics Committee of The First People\u2019s Hospital of Wenling. Informed consent was waived in accordance with ethical guidelines. The research was conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The patient\u2019s legal guardians provided written informed consent to publish this case.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"587"}}